Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
APG-2449 by Ascentage Pharma Group International for Ovarian Cancer: Likelihood of Approval
APG-2449 is under clinical development by Ascentage Pharma Group International and currently in Phase II for Ovarian Cancer. According to...
APG-2449 by Ascentage Pharma Group International for Fallopian Tube Cancer: Likelihood of Approval
APG-2449 is under clinical development by Ascentage Pharma Group International and currently in Phase II for Fallopian Tube Cancer. According...
APG-2449 by Ascentage Pharma Group International for Peritoneal Cancer: Likelihood of Approval
APG-2449 is under clinical development by Ascentage Pharma Group International and currently in Phase II for Peritoneal Cancer. According to...